In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Medical Services Patients & Visitors Health Library For Medical Professionals Quality About Us PhysicianLink
Text Size:  -   +  |  Print Page  |  Email Page

Ovarian and Peritoneal Cancer



A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or CT-2103 (IND# 70177) Versus No treatment Until Documented Relapse in Women with Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer Who Achieve a Complete Clinical Response to Primary Platinum / Taxane Chemotherapy.

    For additional information please contact Heather Tudor, Clinical Research Coordinator, at 859-260-3196.
    REF# CBH 09-877

Quality of Life and Care Needs in Patients with Persistent or Recurrent Platinum-Resistant Ovarian, Fallopian Tube, and Peritoneal Cancer.

For additional information please contact Heather Tudor, Clinical Research Coordinator, at 859-260-3196.
REF# CBH 11-999

GOG-0273:  Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer.

For additional information please contact Heather Tudor, Clinical Research Coordinator, at 859-260-3196.
REF# CBH 12-1066

A Prospective, Longitudinal Study of YKL-40 in Patients with FIGO Stage III or IV Invasive Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Undergoing Primary Chemotherapy.

      

       For additional information please contact Heather Tudor, Clinical Research Coordinator, at 859-260-3196. 

       REF# BHL 13-1103